Nancy Jean Cox to Antibodies, Viral
This is a "connection" page, showing publications Nancy Jean Cox has written about Antibodies, Viral.
Connection Strength
0.746
-
COVID-19 vaccines: call for global push to maintain efficacy. Nature. 2021 02; 590(7844):36.
Score: 0.174
-
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009 Nov 12; 361(20):1945-52.
Score: 0.079
-
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol. 2009 Mar; 16(3):265-73.
Score: 0.076
-
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis. 2000 Jan; 181(1):344-8.
Score: 0.040
-
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis. 1999 Dec; 180(6):1763-70.
Score: 0.040
-
Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol. 1999 Apr; 37(4):937-43.
Score: 0.038
-
Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis. 1999 Mar; 28(3):541-7.
Score: 0.038
-
Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine. 1995; 13(15):1399-402.
Score: 0.029
-
Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model. Clin Vaccine Immunol. 2014 May; 21(5):722-31.
Score: 0.027
-
Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. J Infect Dis. 2011 Nov 15; 204(10):1491-9.
Score: 0.023
-
Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem. 2011 Jun 15; 83(12):4729-37.
Score: 0.022
-
Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol. 1990; 8:737-71.
Score: 0.020
-
Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Influenza Other Respir Viruses. 2009 Nov; 3(6):287-95.
Score: 0.020
-
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009 Jul 10; 325(5937):197-201.
Score: 0.019
-
Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008 Dec 08; 168(22):2405-14.
Score: 0.019
-
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis. 2006 Oct 15; 194(8):1032-9.
Score: 0.016
-
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine. 2006 Nov 17; 24(47-48):6859-66.
Score: 0.016
-
Transmission of equine influenza virus to dogs. Science. 2005 Oct 21; 310(5747):482-5.
Score: 0.015
-
Pathogenicity and antigenicity of a new influenza A (H5N1) virus isolated from duck meat. J Med Virol. 2003 Apr; 69(4):553-9.
Score: 0.013
-
Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999. Emerg Infect Dis. 2002 Feb; 8(2):154-9.
Score: 0.012
-
Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine. 2000 Sep 15; 19(2-3):308-18.
Score: 0.011